TAG Welcomes Price Reductions for TB Medicines
Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.
TAGline Spring 2018
Bend the Curves: Incremental change—activism that successfully defends or advances critical research or policy—can sometimes feel inconsequential, particularly when it is hard won, resource intensive, and intangible.
Combating Rising Tuberculosis in New York
As unbelievable as it sounds in 2018, despite being preventable and curable Tuberculosis (TB) is on the rise in New York City for the first time in 25 years. Cases of drug-resistant TB, which are much more difficult and costly…
In a State of Disunion: HIV, TB, and HCV Elimination Policies and Priorities Under the Trump Administration
By Suraj Madoori During Trump’s first-ever State of the Union address on January 30, activists observed a dearth of clear priorities to eliminate HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV) in the U.S. Science and longstanding bipartisan interest in…
New York Community Groups Call on City, State, Federal Actors to Increase Funding for Tuberculosis
Advocates alarmed that budget cuts led to first rise in TB cases in New York City in over 25 years.
It’s Time to Deliver – Including Pregnant and Lactating Women in Clinical Research
Pregnant women have frequently been excluded from or de-prioritized in clinical research initiatives due to a multitude of factors, such as the complex physiology of pregnant women, the risk studies may pose to the fetus, and the classification of pregnant…
World Health Organization Guidelines for the Treatment of Multidrug-Resistant Tuberculosis
Letter to Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO, and Dr. Tereza Kasaeva, Global TB Program Director.
Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide
August 23, 2019 –This guide is for people who have tuberculosis (TB), people who are at risk for it, and the people who take care of them. It explains what global standards are for TB prevention, treatment, and care, so…
Good COPs or Bad COPs? Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs)
Good COPs or Bad COPs: Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs). Every year, PEPFAR meets to discuss their strategy and budget for the following year, and set targets on implementing country operation…
Securing a Tuberculosis-Free Future through the Visionary Research of the CDC’s Tuberculosis Trials Consortium
January 10, 2018 – The Tuberculosis Trials Consortium (TBTC) is a global leader in research and development for better tools to prevent, diagnose, and treat tuberculosis (TB). Housed within the U.S. Centers for Disease Control and Prevention (CDC), the TBTC conducts clinical…